<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01827748</url>
  </required_header>
  <id_info>
    <org_study_id>FA120928</org_study_id>
    <nct_id>NCT01827748</nct_id>
  </id_info>
  <brief_title>Evaluation of a Surgical Microscope Mounted Autorefractor When Used on Patients Lying in a Supine Position</brief_title>
  <official_title>Evaluation of a Surgical Microscope Mounted Autorefractor When Used on Patients Lying in a Supine Position</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Adventus Technology</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Adventus Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the accuracy and repeatability of an individually&#xD;
      validated prototype autorefractor designed to be mounted on a surgical microscope.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate the accuracy and repeatability of an individually&#xD;
      validated prototype autorefractor designed to be mounted on a surgical microscope. The goal&#xD;
      is to evaluate 20 subjects with both the investigational instrument followed by a&#xD;
      commercially available instrument.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of the accuracy and repeatability of the Test device compared to the Control</measure>
    <time_frame>1 Hour</time_frame>
    <description>Comparative auto refractor device measurement variation is defined as +/-0.25 Diopters</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Refractive Error</condition>
  <arm_group>
    <arm_group_label>Intraoperative Autorefractor IAR-1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This is a auto refractor mounted on an operating microscope.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hartmann-Shack Auto Refractor</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The Hartmann-Shack type auto refractor used with the subject sitting upright in front of the instrument.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intraoperative Autorefractor IAR-1</intervention_name>
    <description>This is an auto-refractor mounted on an operating microscope and used with the subject in a supine position</description>
    <arm_group_label>Intraoperative Autorefractor IAR-1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hartmann-Shack Auto Refractor</intervention_name>
    <description>Standard auto-refractor used with subject sitting upright in front of the instrument.</description>
    <arm_group_label>Hartmann-Shack Auto Refractor</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Be at least 18 years of age as of the date of evaluation for the study.&#xD;
&#xD;
          2. Have:&#xD;
&#xD;
               1. Read the Informed Consent&#xD;
&#xD;
               2. been given an explanation of the Informed Consent&#xD;
&#xD;
               3. indicated understanding of the Informed Consent&#xD;
&#xD;
               4. signed the Informed Consent document.&#xD;
&#xD;
          3. Be willing and able to adhere to the instructions set forth in this protocol and able&#xD;
             to participate in all scheduled evaluations.&#xD;
&#xD;
          4. Be in good general health, based on his/her knowledge.&#xD;
&#xD;
          5. Have a refractive error within the range of -10.00 to +30.00 Diopter sphere and up to&#xD;
             5.00 Diopter of refractive cylinder .&#xD;
&#xD;
          6. Have manifest refraction (BCVA) Snellen visual acuities (VA) equal to or better than&#xD;
             20/25 in each eye. -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Subjects may not be enrolled in this study if any of the following apply: The subject&#xD;
        is/has:&#xD;
&#xD;
          1. Allergy to Tropicamide or a previous adverse reaction to Tropicamide.&#xD;
&#xD;
          2. Poor personal hygiene as observed by the investigational site personnel.&#xD;
&#xD;
          3. Strabismus&#xD;
&#xD;
          4. Currently pregnant (to the best of the subject's knowledge) or is lactating.&#xD;
&#xD;
          5. Previous refractive surgery or current or previous orthokeratology treatment.&#xD;
&#xD;
          6. Aphakic or pseudophakic or has cataracts that interfere with visual acuity.&#xD;
&#xD;
          7. Ocular or systemic disease such as, but not limited to: anterior uveitis or iritis&#xD;
             (past or present), glaucoma, Sj√∂gren's syndrome, lupus erythematosus, sclerodermia,&#xD;
             keratoconus or type II diabetes.&#xD;
&#xD;
          8. The need for topical ocular medications or any medication which might interfere with&#xD;
             the study evaluations.&#xD;
&#xD;
          9. The presence of clinically significant (grade 3 or 4) anterior segment abnormalities;&#xD;
             inflammations such as iritis; or any infection of the eye, lids, or associated&#xD;
             structures.&#xD;
&#xD;
         10. Slit lamp findings, including but not limited to:&#xD;
&#xD;
        Pathological dry eye or associated dry eye symptoms with decreased tear levels and&#xD;
        punctuate staining &gt; Grade 2 Pterygium Corneal scars within the visual axis&#xD;
        Neovascularization or ghost vessels &gt; 1.0 mm in from the limbus Giant papillary&#xD;
        conjunctivitis (GPC) of &gt; Grade 2 Anterior uveitis or iritis Seborrheic eczema, seborrheic&#xD;
        conjunctivitis or blepharitis&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gregg Berdy, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>Ophthalmology Associates</name>
      <address>
        <city>St Louis</city>
        <state>Missouri</state>
        <zip>63131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <study_first_submitted>March 29, 2013</study_first_submitted>
  <study_first_submitted_qc>April 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 10, 2013</study_first_posted>
  <last_update_submitted>April 11, 2013</last_update_submitted>
  <last_update_submitted_qc>April 11, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 12, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Autorefractor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>June 4, 2018</submitted>
    <returned>July 2, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

